Meeting
2023 ASCO Quality Care Symposium
Improving bivalent COVID-19 vaccination rates among adult patients with cancer: An ASCO/CDC initiative.
Authors
Michael Jisoo Lee
San Francisco Medical Center, Kaiser Permanente Northern California, San Francisco, CA
Michael Jisoo Lee, Cecile Laurent, Janise M. Roh, Lawrence H. Kushi, Raymond Liu, Piyush Srivastava, Lisa Y. Law
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Quality Improvement Research and Implementation Science
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 427)
DOI
10.1200/OP.2023.19.11_suppl.427
Abstract #
427
Poster Bd #
J9
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
The effect of corticosteroid on immunogenicity of SARS-CoV-2 vaccines in solid cancer patients.
First Author: Chayanee Samdaengpan
Poster
2023 ASCO Annual Meeting
Efficacy of COVID vaccinations in patients with chronic lymphocytic leukemia.
First Author: Kaitlin Annunzio
Poster
2023 ASCO Genitourinary Cancers Symposium
COVID-19 vaccines in patients with urothelial cancers receiving immune checkpoint inhibitors.
First Author: Danielle Gilbert
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical characteristics and outcomes of SARS-CoV-2 infection in patients with genitourinary cancer.
First Author: Dorothy Kenny